These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1884 related items for PubMed ID: 15185900

  • 1. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [Abstract] [Full Text] [Related]

  • 2. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E, Gallo P, Damiano M, Scognamiglio G, De Simone C, Nilo S, Guarini P, Mascioli G, Curnis A.
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388
    [Abstract] [Full Text] [Related]

  • 4. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.
    J Med Assoc Thai; 2007 Jul 15; 90(7):1458-66. PubMed ID: 17710992
    [Abstract] [Full Text] [Related]

  • 5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 6. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT, Martinelli Filho M, Lima CE, Martins DG, Nishióka SA, Pedrosa AA, Crevelari ES, Costa R, Sosa EA, Ramires JA.
    Arq Bras Cardiol; 2008 Feb 15; 90(2):138-43. PubMed ID: 18392387
    [Abstract] [Full Text] [Related]

  • 7. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T, Yoshida T, Hiraki T, Ohe M, Takeuchi T, Nagamoto Y, Fukuda Y, Gondo T, Imaizumi T.
    Europace; 2008 Mar 15; 10(3):379-83. PubMed ID: 18227354
    [Abstract] [Full Text] [Related]

  • 8. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.
    Pacing Clin Electrophysiol; 2007 Feb 15; 30(2):193-8. PubMed ID: 17338715
    [Abstract] [Full Text] [Related]

  • 9. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.
    J Card Fail; 2008 Feb 15; 14(1):9-18. PubMed ID: 18226768
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ.
    Am J Cardiol; 2007 Dec 01; 100(11):1665-70. PubMed ID: 18036366
    [Abstract] [Full Text] [Related]

  • 11. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group.
    Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095
    [Abstract] [Full Text] [Related]

  • 12. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A, Lewicka-Nowak E, Dabrowska-Kugacka A, Kempa M, Tybura S, Szwoch M, Królak T, Raczak G.
    Kardiol Pol; 2008 Jan 02; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L, Da Costa A, Dauphinot V, Romeyer-Bouchard C, Khris L, M'baye A, Isaaz K.
    Europace; 2010 Aug 02; 12(8):1141-8. PubMed ID: 20573673
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.